PRP10- PREDICTING THE BENEFIT OF OPTIMIZING SEVERE ASTHMA MANAGEMENT IN A MANAGED CARE SETTING-A COST-BENEFIT ANALYSIS COMPARING THE COMBINATION OF FLUTICASONE PROPIONATE AND SALMETEROL (FPS) AND ZAFIRLUKAST
May 1, 2003, 00:00 AM
10.1016/S1098-3015(10)64270-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)64270-2/fulltext
Section Title :
Section Order :
471
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64270-2&doi=10.1016/S1098-3015(10)64270-2